Category:Hypomethylating agents
Jump to navigation
Jump to search
A class of antineoplastics that inhibit DNA methylation, thus causing changes in gene expression. The exact mechanism by which this causes cancer cell death is unclear, but these have demonstrated efficacy mostly in the myeloid malignancies.